<DOC>
	<DOCNO>NCT01328197</DOCNO>
	<brief_summary>The primary goal study assess safety performance Treovance device subject infrarenal aortic aneurysm , specifically evaluate diseased pathology treat acceptable adverse event rate device performs expect . The result study permit establishment endpoint clinical design subsequent U.S. trial .</brief_summary>
	<brief_title>Treovance Stent-Graft With Navitel Delivery System Patients With Infrarenal Abdominal Aortic Aneurysms</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<criteria>Subjects diagnose infrarenal abdominal aortic aneurysm ( AAA ) , without iliac artery involvement Subjects infrarenal AAA &gt; /= 4.5 cm diameter male , &gt; /= 4.0 cm diameter female , increase diameter 0.5 cm last 6 month Subjects consent participate Subjects agree comply followup schedule Subjects dissection , rupture aneurysm , symptomatic aneurysm Subjects prior AAA repair Subjects medical condition would complicate endovascular procedure confound result ( e.g. , Marfan 's syndrome , morbid obesity , severe coronary artery disease ) Subjects pregnant lactate Subjects participate investigational study Subjects less 2 year life expectancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Treovance</keyword>
	<keyword>aneurysm</keyword>
	<keyword>AAA</keyword>
</DOC>